M&A Deal Summary |
|
|---|---|
| Date | 2023-11-10 |
| Target | ViroStat |
| Sector | Life Science |
| Buyer(s) | Medix Biochemica |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1985 |
| Sector | Life Science |
| Employees | 267 |
| Revenue | 70M EUR (2023) |
Medix Biochemica develops, manufactures, and markets critical raw materials including antibodies, antigens, and biologicals for IVD companies worldwide. Medix Biochemica was founded in 1985 and is based in Espoo, Finland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| State: Maine M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-13 |
Diaclone
Besancon, France Diaclone provides expertise in the fields of inflammation, oncology, and immunology. The company offers best-in-class monoclonal antibodies, high-quality ELISA and ELISPOT kits as well as custom services ranging from immunoassay kit development to new antibody discovery using hybridoma and phage display technologies to a broad range of IVD, life science, and pharma customers. Diaclone was formed in 1986 and is based in Besancon, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-01-22 |
Candor
Wangen, Germany Candor is a provider of a comprehensive selection of premium solutions for immunoassays, including HAMA and interference blockers, surface blockers, stabilizers, and buffer solutions. Candor was founded in 2004 and is based in Wangen, Germany. |
Buy | - |
